• 1
    American Cancer Society. Cancer Facts and Figures 2004. Atlanta, GA: American Cancer Society, 2004.
  • 2
    Clegg LXP, Li FPM, Hankey BFS, Chu KP, Edwards BKP. Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) program population-based study. Arch Intern Med. 2002; 162: 19851993.
  • 3
    Zeigler-Johnson C. CYP3A4: a potential prostate cancer risk factor for high-risk groups. Clin J Oncol Nurs. 2001; 5: 153154.
  • 4
    Powell IJ, Meyskens FL Jr. African American men and hereditary/familial prostate cancer: intermediate-risk populations for chemoprevention trials. Urology. 2001; 57(Suppl): 81.
  • 5
    Powell IJ. Prostate cancer in the African American: is this a different disease? [review]. Semin Urol Oncol. 1998; 16: 221226.
  • 6
    Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate. 2003; 56: 256262.
  • 7
    Narain V, Cher ML, Wood DPJ. Prostate cancer diagnosis, staging and survival. Cancer Metastasis Rev. 2002; 21: 1727.
  • 8
    American Cancer Society. Cancer Facts Figures 2003. New York: American Cancer Society, 2003.
  • 9
    Bratt O, Damber JE, Emanuelsson M, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer. 2000; 36: 235241.
  • 10
    Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003; 97: 18941903.
  • 11
    Cooney KA. Hereditary prostate cancer in African-American families [review]. Semin Urol Oncol. 1998; 16: 202206.
  • 12
    Cotter MP, Gern RW, Ho GY, Chang RY, Burk RD. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate. 2002; 50: 216221.
  • 13
    Grumet SC, Bruner DW. The identification and screening of men at high risk for developing prostate cancer [review]. Urol Nurs. 2000; 20: 1518.
  • 14
    Makinen T, Tammela TL, Stenman UH, et al. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol. 1920; 26582663.
  • 15
    Virtanen A, Gomari M, Kranse R, Stenman UH. Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables. Clin Chem. 1999; 45: 987994.
  • 16
    Catalona WJ, Antenor JA, Roehl KA, Moul JW. Screening for prostate cancer in high risk populations. J Urol. 2002; 168: 19801983.
  • 17
    Makinen T, Tammela TL, Stenman UH, et al. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol. 2002; 20: 26582663.
  • 18
    Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992; 89: 33673371.
  • 19
    Cooney KA, McCarthy JD, Lange E, et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study [comment]. J Natl Cancer Inst. 1997; 89: 955959.
  • 20
    Myers RE. African American men, prostate cancer early detection examination use, and informed decision-making. Semin Oncol. 1999; 26: 375381.
  • 21
    Powell IJ, Heilbrun L, Littrup PL, Franklin A, Parzuchowski MS, Gelfand D. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J Urol. 1997; 158: 146149.
  • 22
    Powell IJ, Carpten J, Dunston G, et al. African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc. 2001; 93(Suppl): 28S.
  • 23
    Robinson SB, Ashley M, Haynes MA. Attitude of African-Americans regarding prostate cancer clinical trials. J Community Health. 1996; 21: 7787.
  • 24
    Weinrich SP, Boyd MD, Bradford D, Mossa MS, Weinrich M. Recruitment of African Americans into prostate cancer screening. Cancer Pract. 1998; 6: 2330.
  • 25
    Eyre HJ, Feldman GE. Status report on prostate cancer in African Americans: a national blueprint for action. CA Cancer J Clin. 1998; 48: 315319.
  • 26
    Stone BA. Prostate cancer early detection in African-American men: a priority for the 21st century. J Natl Med Assoc. 1998; 90(Suppl): 7.
  • 27
    Donini-Lenhoff FG, Hedrick HL. Increasing awareness and implementation of cultural competence principles in health professions education. J Allied Health. 2000; 29: 241245.
  • 28
    Weinrich S. The debate about prostate cancer screening: what nurses need to know. Semin Oncol Nurs. 2001; 17: 7884.
  • 29
    Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I. Prior probability and effectiveness of tests. The American College of Physicians [review]. Ann Intern Med. 1997; 126: 394406.
  • 30
    Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening [comment]. Arch Intern Med. 1996; 156: 13331336.
  • 31
    Cantor SB, Spann SJ, Volk RJ, Cardenas MP, Warren MM. Prostate cancer screening: a decision analysis [comment]. J Family Pract. 1995; 41: 3341.
  • 32
    Albertsen PC, Hanley JA, Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005; 293: 20952101.
  • 33
    Carter BS, Bova GS, Beaty TH, et al. Hereditary prostate cancer: epidemiologic and clinical features [review]. J Urol. 1993; 150: 797802.
  • 34
    Carter BS, Steinberg GD, Beaty TH, Childs B, Walsh PC. Familial risk factors for prostate cancer [review]. Cancer Surv. 1991; 11: 513.
  • 35
    Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology. 2004; 13: 8085.
  • 36
    Reiss-Starr CA, Weinrich SP, Creanga D, Weinrich M. The association between family history and participation in free prostate cancer screening. Am J Health Stud. 1998; 14: 95104.
  • 37
    Bock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA. Prostate cancer early detection practices among men with a family history of disease. Urology. 2003; 62: 470475.
  • 38
    Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med. 2001; 24: 247258.
  • 39
    Cormier L, Reid K, Kwan L, Litwin MS. Screening behavior in brothers and sons of men with prostate cancer. J Urol. 2003; 169: 17151719.
  • 40
    Sartor O. Early detection of prostate cancer in African-American men with an increased familial risk of disease. J La State Med Soc. 1996; 148: 179185.
  • 41
    Powell IJ, Carpten J, Dunston G, et al. African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc. 2001; 93: 120123.
  • 42
    Royal C, Baffoe-Bonnie A, Kittles R, et al. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol. 2000; 10(Suppl): 77.
  • 43
    Reynolds T. Study seeks to clarify genetic basis of prostate cancer in African Americans. J Natl Cancer Inst. 2003; 95: 13561357.
  • 44
    Centers for Disease Control. National Health Interview Survey., 2003.
  • 45
    SUDAAN. Research Triangle Institute, Research Triangle Park, Cary, NC, 2004.
  • 46
    Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003; 289: 14141420.